EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma proteins and antibody immune responses in non-small cell lung cancer: Evidence from Mendelian randomization, mediation analysis, and single-cell transcriptomics

Ling Wu, Huijing Feng, Lixun Chai, Xiaofeng Luo, Chenhui Zhao, Yunfei Wang iD

Journal of International Medical Research · 2026-11 · 54 (11)

DOI: 10.1177/03000605261506563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of International Medical Research, online erschienen am 16.11.2026. Verfasst von Ling Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Oncology, Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical Univers…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Blood Proteins. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Project of Health Commission of Shanxi Province, Fundamental Research Program of Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the potential causal relationships between circulating plasma proteins and non-small cell lung cancer and to assess whether antibody immune response traits mediate these associations.

Methods

We conducted an integrative genetic epidemiology study combining two-sample Mendelian randomization, mediation analysis, single-cell transcriptomics, and tissue-based experimental validation. Plasma protein data for 4907 proteins and genome-wide association study summary statistics for 46 antibody immune response traits were analyzed alongside non-small cell lung cancer genome-wide association study data from 218,792 individuals of European ancestry (1627 cases and 217,165 controls). Five complementary Mendelian randomization methods were applied; sensitivity analyses assessed heterogeneity, horizontal pleiotropy, and robustness, and reverse Mendelian randomization assessed potential reverse causation. Mediation analysis evaluated antibody immune response traits as candidate intermediate phenotypes. Prioritized proteins were further characterized using single-cell RNA sequencing data and paired tumor and adjacent normal tissues from patients with histopathologically confirmed non-small cell lung cancer.

Results

We identified 1188 plasma proteins with potential causal associations with non-small cell lung cancer risk. CLEC10A and TGM3 were prioritized through sequential plasma protein–non-small cell lung cancer, plasma protein–antibody immune response, and mediation analyses. Higher genetically predicted CLEC10A levels were associated with increased non-small cell lung cancer risk, whereas higher genetically predicted TGM3 levels were associated with lower non-small cell lung cancer risk. Five antibody immune response traits were initially associated with non-small cell lung cancer, of which four were retained after robustness assessment. Mediation analysis identified three candidate plasma protein–antibody immune response–non-small cell lung cancer pathways involving GCST90006921 and GCST90006923. Single-cell analysis localized CLEC10A and TGM3 predominantly to macrophages, while paired tissue analyses showed higher CLEC10A and lower TGM3 expression in tumors.

Conclusions

CLEC10A and TGM3 may contribute to non-small cell lung cancer susceptibility, with specific antibody immune response traits representing candidate intermediate immune pathways. These findings provide genetic and complementary biological support for further independent replication and mechanistic investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsBlood ProteinsHumansMendelian Randomization AnalysisGenome-Wide Association StudySingle-Cell AnalysisTranscriptomePolymorphism, Single NucleotideSingle-Cell Gene Expression AnalysisLectins, C-Type

Stichwörter der Autor:innen

Mendelian randomizationNon-small cell lung cancerantibody immune responsemediation analysisplasma proteinssingle-cell RNA sequencing

Substanzen

Blood ProteinsLectins, C-Type

Autor:innen und Institutionen

  • Department of Thoracic Oncology, Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, China.
  • Department of Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, China.
  • School of Mathematics, North University of China, China.

ORCID-Profile: Yunfei Wang

Förderung

  • Scientific Research Project of Health Commission of Shanxi Province
  • Fundamental Research Program of Shanxi Province

Zitieren

APA

Wu, L., Feng, H., Chai, L., Luo, X., Zhao, C., & Wang, Y. (2026). Plasma proteins and antibody immune responses in non-small cell lung cancer: Evidence from Mendelian randomization, mediation analysis, and single-cell transcriptomics. Journal of International Medical Research, 54(11). https://doi.org/10.1177/03000605261506563

Vancouver

Wu L, Feng H, Chai L, Luo X, Zhao C, Wang Y. Plasma proteins and antibody immune responses in non-small cell lung cancer: Evidence from Mendelian randomization, mediation analysis, and single-cell transcriptomics. Journal of International Medical Research. 2026;54(11). doi:10.1177/03000605261506563

BibTeX
@article{Wu2026,
  author = {Wu, Ling and Feng, Huijing and Chai, Lixun and Luo, Xiaofeng and Zhao, Chenhui and Wang, Yunfei},
  title = {Plasma proteins and antibody immune responses in non-small cell lung cancer: Evidence from Mendelian randomization, mediation analysis, and single-cell transcriptomics},
  journal = {Journal of International Medical Research},
  year = {2026},
  volume = {54},
  number = {11},
  doi = {10.1177/03000605261506563}
}
Kostenlos starten →